Table 1.
Patient characteristics
| Variable | No. of patients (%) |
|---|---|
| No. of patients | 230 (100) |
| Age: Median [range], y | 49 [13–78] |
| Gender | |
| Female | 26 (11.3) |
| Male | 204 (88.7) |
| HBsAg | |
| Negative | 15 (6.5) |
| Positive | 215 (93.5) |
| AFP: Median [range], ng/mL | 157.3 [0.6-121000] |
| GGT: Median [range], U/l | 45.0 [3.5-655.5] |
| Tumor size: Median [range], cm | 4.6 [1.0-18.0] |
| Liver cirrhosis | |
| No | 50 (21.7) |
| Yes | 180 (78.3) |
| Child-Pugh class | |
| A | 225 (97.8) |
| B | 5 (2.2) |
| Tumor number | |
| Single | 213 (92.6) |
| Multiple | 17 (7.4) |
| Satellite nodule | |
| No | 199 (86.5) |
| Yes | 31 (13.5) |
| Tumor capsule | |
| No/incomplete | 141 (61.3) |
| Complete | 89 (38.7) |
| Tumor differentiation | |
| I | 14 (6.1) |
| II | 143 (62.2) |
| III | 66 (28.7) |
| IV | 7 (3.0) |
| Vascular invasion | |
| No | 207 (90.0) |
| Yes | 23 (10.0) |
| TNM stage | |
| I | 178 (77.4) |
| II | 11 (4.8) |
| III | 41 (17.8) |
| BCLC stage | |
| 0 | 20 (8.7) |
| A | 106 (46.1) |
| B | 80 (34.8) |
| C | 24 (10.4) |
| Recurrence status | |
| No | 105 (45.6) |
| Early recurrence | 85 (37.0) |
| Late recurrence | 40 (17.4) |